Tilray Brands (TLRY) Other financing activities (2019 - 2020)

Tilray Brands (TLRY) posted Other financing activities of $4000.0 for Q3 2020, down 99.32% on a QoQ basis from $585000.0 in Q2 2020.

Tilray Brands (TLRY) Other financing activities (2019 - 2020) Analysis & Trends

Tilray Brands' Other financing activities history runs 2 years deep, the most recent figure standing at $4000.0 for Q3 2020.

Quarterly Other financing activities changed N/A year-over-year to $4000.0 in Q3 2020, while the trailing twelve-month figure through Feb 2026 was $589000.0 (down 69.67% YoY) and the FY2021 annual result came in at $144000.0, down 96.32% from the prior year.
Other financing activities was $4000.0 for Q3 2020 at Tilray Brands, down from $585000.0 in the prior quarter.
Across five years, Other financing activities topped out at $1.4 million in Q1 2020 and bottomed at -$155.6 million in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Tilray Brands	465.02 Mn	373.06 Mn	54.95 Mn

Download Data